The degree of saponification, which is a dissolution characteristic of poly(vinyl alcohol) (PVA), is used to blend PVA to prepare a hydrogel microneedle (MN) patch. The MN patch was manufactured with an adjustable disassembly time using a molding process, and it was confirmed to have morphological stability and excellent needle formation. The permeability of the gelatin sheet, which is analogous to the skin elasticity coefficient of a real human, was confirmed. The penetration ratio had a very high value of 100% and sufficient physical properties to penetrate the skin. In the disassembly experiment, the MN patch was produced with ratios of lower:higher saponification of 6:4 (PVA6), 7:3 (PVA7), 8:2 (PVA8), 9:1 (PVA9), and 10:0 (PVA10). Degradation did not occur for PVA6 and PVA7 but occurred for PVA8, PVA9, and PVA10. A cytotoxicity test to investigate its suitability for use in the human body confirmed the cell viability of 80% or more and nontoxic properties. Therefore, sufficient cell viability was confirmed when compared to the existing products.
The degree of saponification, which is a dissolution characteristic of poly(vinyl alcohol) (PVA), is used to blend PVA to prepare a hydrogel microneedle (MN) patch. The MN patch was manufactured with an adjustable disassembly time using a molding process, and it was confirmed to have morphological stability and excellent needle formation. The permeability of the gelatin sheet, which is analogous to the skin elasticity coefficient of a real human, was confirmed. The penetration ratio had a very high value of 100% and sufficient physical properties to penetrate the skin. In the disassembly experiment, the MN patch was produced with ratios of lower:higher saponification of 6:4 (PVA6), 7:3 (PVA7), 8:2 (PVA8), 9:1 (PVA9), and 10:0 (PVA10). Degradation did not occur for PVA6 and PVA7 but occurred for PVA8, PVA9, and PVA10. A cytotoxicity test to investigate its suitability for use in the human body confirmed the cell viability of 80% or more and nontoxic properties. Therefore, sufficient cell viability was confirmed when compared to the existing products.
Although oral administration
accounts for the majority of drug
delivery methods, it has limitations in cosmetology where immediate
effects are desired, and it is questionable whether the drug is actually
effective.[1] A transdermal drug delivery
system (TDDS) is the most notable and attractive method to compensate
for such shortcomings by effectively conveying the active ingredient
to the desired layer of the skin.[2]However, the corneal layer is the main barrier to drug penetration,
so substances that can be delivered via the transdermal route are
limited to small (<500 Da) intermediate hydrophobic compounds.[1,3] Microneedle (MN) arrays use tens to hundreds of micron-sized needles,
providing a painless option to increase skin permeability and enhance
transdermal transmission.[2,4] This technique can be
used to create micropores in which the drug diffuses into the microcirculation
of the skin to provide a minimally invasive, comprehensive therapeutic
polymer across the skin surface and epidermis.[5] This microneedle array can be implemented in various applications,
such as medical diagnosis, home diagnosis, beauty/clinic, medical
treatment, and medical equipment.MN patch manufacturing methods
can be broadly divided into two
types: micro-mold-free methods and micromolding methods.[6−8] The distribution methods for MN patches include solid microneedles,
hollow microneedles, coated microneedles, swellable microneedles,
and dissolving microneedles.[7,8] Among these methods,
the following paper produced a biodegradable MN patch by preparing
an MN patch via micromolding and solving microneedles using a poly(vinyl
alcohol) (PVA)-based hydrogel. This system can be applied not only
to functional substances but also to synthetic chemical drugs and
biopharmaceuticals in polymer materials, with the possibility of expanding
its use to the medical field.We used PVA for the fabrication
of the MN patch owing to the advantages
of water solubility, biocompatibility, and excellent physical properties.[15−17,20] Also, PVA has promising biomedical
applications in various fields such as tissue mimicking, vascular
cell culturing, and implanting. Especially, transparent PVA hydrogel
has been used for minimal-invasive surgery with needle intervention.[18] Moreover, the microneedle is an efficient platform
to make easy handling and reduce the fear of invasiveness.[21] Among these advantages, solubility is a significant
factor in biodegradable MN patches that determines the properties
of PVA because it is highly dependent on saponification.[9,10] Substances with a degree of saponification of 99.0 mol % or more
have a strong intermolecular hydrogen bond and a high melting point
due to increased conversion to alcohol in acetic acid, and they are
difficult to dissolve in water. Therefore, we have tried to improve
the solubility by adding a substance with a low degree of saponification.[10] The PVA with higher saponification used Mw 85,000–124,000, >99% hydrolyzed,
and
the lower saponification also used Mw 13,000–23,000,
87–89% hydrolyzed.
Materials and Methods
Materials
As shown in Figure , the template (Smicna, Pte.
Ltd.) used in the molding process provides a needle length of 500
μm in width and a length of 30 × 30 mm2, consisting
of silicone material. Two types of PVA are used in the production
of MN patches, poly(vinyl alcohol) (PVA) of Mw 74,800, 97–100 mol % hydrolyzed (Tokyo Chemical Industry
Co., Ltd.), and PVA of Mw 13,000–23,000,
87–89% hydrolyzed (Sigma Aldrich Chemistry Co., Ltd.). For
the dye, marine sponge pigment (Microbulbifer echini; MPRBM-20201022008)
and methylene blue solution (Sigma Aldrich Chemistry Co., Ltd.) were
used.
Figure 1
Mold for MN patch fabrication.
Mold for MN patch fabrication.
PVA-Based MN Patch Fabrication
A
patch was prepared by introducing a PVA blend solution into the mold
and applying a solution casting method of drying as it is under certain
conditions. Low-saponification PVA and high-saponification PVA were
used in the ratio of 10:0 (PVA10), 9:1 (PVA9), 7:3 (PVA7), 5:5 (PVA5),
3:7 (PVA3), 1:9 (PVA1), and 0:10 (PVA) to prepare the PVA solutions,
and these samples were used for the measurement of mechanical properties.
Additionally, PVA6 (6:4) and PVA8 (8:2) were conducted by penetration
and degradation tests, differential scanning calorimetry (DSC), and
thermogravimetric analysis (TGA). Ten milliliters of distilled water
was mixed (10 wt %) so that the total PVA weight was 1 g. Then, the
mixture was thoroughly stirred in a water bath to mix the solution.
The solution was poured into a mold and stored in an oven at 40 °C
for 24 h to produce a filmlike MN patch as shown in Figure . Moreover, active ingredients
are added to the PVA-based MN patch to confirm whether active ingredients
remain in the patch after mold processing. The active ingredients
are contained in 5 wt % of the PVA solution.
Figure 2
Molding method of the
MN patch.
Molding method of the
MN patch.
Observation of MN Array Needle Observation
Using Scanning Electron Microscope (SEM) and Optical Microscope
The needles of the prepared MN array patch were well formed, and
their shapes were observed using a scanning electron microscope (SEM;
SU8230, Hitachi, Japan and JSM-7610FPlus, JEOL, Japan) and an optical
microscope.
Measurement of the Physical Properties of
the MN Patches
The mechanical properties were measured using
Universal Testing Machine (UTM, AG-X, Shimadzu, Japan) to check whether
the prepared MN patch had the strength to penetrate the stratum corneum
of the skin. A 500 N load cell was used for the tensile test. The
tensile speed was 60 mm/min. The sample size was 20–25 mm in
length, 5.0 ± 0.2 mm in width, and 0.3 ± 0.14 mm in thickness.
Each tensile experiment was repeated five times for each sample.The compression strength measurement experiment was conducted at
1 mm/min in a 100 N load cell. The sample was used by cutting the
prepared MN patch into an area of one needle. While compressing the
microneedle, the bending strength refers to the section where the
needle endurance bends. This was set as the value of the part where
the force increased constantly and was then rapidly increased.
Degradability Measurement of PVA-Based Patches
Purple pigment[14] extracted from the
marine sponge and 1 wt % of methylene blue solution were added to
the sample for visual confirmation of the degradation. Additional
experiments were conducted under phosphate buffer saline (PBS) (Hyclone),
which appears in the human body. At this time, the sample size was
cut to 2 × 2 cm2. The sample was immersed in PBS to
have an initial hydration process. After that, the mass of the degraded
weight of the sample was measured at regular time intervals. The results
of the exploded view were graphed with percentages of the initial
hydrated mass and the degraded mass.
Measured Skin Permeability of the MN Array
Patches
Gelatin Sheet Preparation
First,
for the permeability experiment, a gelatin sheet with the same elastic
modulus as that of an actual human stratum corneum was prepared.[11] For this reason, gelatin was added to distilled
water at each ratio (5, 7, 10, 15, 20 wt %). Then, after boiling at
40–60 °C, it was poured into a Petri dish and gelated
overnight in the refrigerator. The elastic modulus of the produced
sample was measured through a compression experiment with a UTM.
Measurement of MN Permeability
A sample of MN patches was stained with purple pigment[14] extracted from the marine sponge and methylene
blue for certain samples to see if they could permeate over the gelatin
sheets produced. We put 12 × 10 needles horizontally on a gelatin
sheet and pushed it with a 1 kg weight for about 2 min. The above
sample was removed, and the number of points stained on the sheet
was confirmed. At this time, the permeability was calculated by dividing
the total number of needles in the sample by the number of needles
stained on the sheet. Also, the microneedle was observed by an optical
microscope to ensure the microneedle’s shape degradation (Figure S4).
TGA Measurements of PVA-Based MN Patches
The TGA (TA Instrument SDT Q600) was measured using a sample obtained
by powdering the prepared film-type patch with a freezer grinder (SPEX
6775 Freezer/Mill). It was performed for each sample for 3–5
mg at a heating rate of 10 min in a nitrogen atmosphere. Pyrolysis
occurred for each sample in the programmed temperature range of 25–600
°C, and the continuous weight loss and temperature were recorded
and analyzed.
DSC Measurement of PVA-Based MN Patches
The DSC (2910, TA Instruments) measurement was performed using
samples obtained by powdering the prepared film-type patch with a
freezer grinder (SPEX 6775 Freezer/Mill). PVA10, PVA9, PVA8, PVA7,
and PVA6 samples were heated from 25 to 250 °C at a rate of 10
°C/min. After reaching the target temperature, it was stabilized
for 5 min. While lowering from 250 to 25 °C again, the temperature
was lowered at the rate of 10 °C/min and stabilized for 5 min
after reaching the target temperature. By performing this process
twice, the melting temperature (Tm) and
crystallization temperature (TC) of each
sample could be obtained.
Measurement of the Cytotoxicity of MN Patches
The sample was sterilized with UV at 2.5 × 2.5 cm2. DMEM 89%, FBS 10%, and 2.5 mL of antibiotic 1% were added as the
sample gel, positive control, and negative control, respectively.
After that, the mixture was eluted in a CO2 5% incubator
at 37 °C for 72 h. After subculturing the mMSCs, 10,000 of them
were added to a 96-well plate each, including 100 mL of the culture
solution. After eluting for 72 h, the culture medium in the 96-well
plate was suctioned and the eluate was added. The eluate was put in
a ratio of 1x = 100% eluate; 2x = 50% eluate and 50% culture; 4x 25%
eluate and 75% culture; and 8x = 12.5% eluate and 87.5% culture. After
24 h of adding the eluate, the culture solution: MTS solution (EZ-Cytox)
= 10:1 ratio. Then, after waiting for sufficient color development
for about 1 h, the absorbance was measured.
Results and Discussion
MN Patch Fabrication
The low- and
high-saponification PVA blend MN patches produced through the molding
process were confirmed to have excellent overall shape stability.
The needles were well formed, as shown in Figure , which consists of photographs observed
via SEM and an optical microscope. In addition, the shape stability
was excellent even when the active ingredient was added. After solution
casting of the PVA solution mixed with the active ingredient, Niacinamide
was added. Then, Fourier transform infrared spectroscopy (FT-IR) measurement
confirmed that the active ingredient remained in the patch (Figure S2).
Figure 3
SEM observation image of MN: (a) MN viewed
from above at 1.00 mm
magnification, (b) MN viewed from above at 100 μm magnification,
(c) MN viewed from the side at 1.00 mm magnification, and (d) MN viewed
from the side at 100 μm magnification.
SEM observation image of MN: (a) MN viewed
from above at 1.00 mm
magnification, (b) MN viewed from above at 100 μm magnification,
(c) MN viewed from the side at 1.00 mm magnification, and (d) MN viewed
from the side at 100 μm magnification.
Measurement of Mechanical Properties and Strength
of the MN
Mechanical properties of MN patch were conducted
by a tensile test. Figure indicates the graphs of the fracture stress, fracture strain,
and elastic modulus. The fracture stress–fracture strain curve
showed that mechanical properties of PVA decreased according to the
degree of saponification because the high degree of saponification
of PVA was more translated into the alcohol group than in the lower
group. Therefore, the high degree of saponification has a lot of hydrogen
bonds.[23,24] This structure leads to higher levels of
stress and strain. However, PVA9 and PVA10, with a low degree of saponification,
have more acetate groups, which makes the distance between molecular
chains remote and intermolecular hydrogen bonds weak. As a result
of this, PVA9 and PVA10 have increased strength.[25] The elastic modulus also decreased depending on the saponification
ratio and showed a similar trend with the fracture stress (Figure a). The result of
the compression test to confirm the strength of the fabricated needle
is as shown in Figure b, the force decreased rapidly at 1.37 N. The moment when the force
declines momentarily indicates that the needle was bent (Figure c). This value is
considered to indicate that the needle can penetrate the skin when
it has a strength of 0.08 N/needle, as shown in previous studies.[22] Therefore, it can be seen to have sufficient
physical properties for skin penetration.[11,12]
Figure 4
Graph
of the physical properties of the MN patch and images. (a)
This graph presents the tensile strength, indicating the x-axis PVA0, PVA1, PVA3, PVA5, PVA7, PVA9, and PVA10, and the y-axis fracture stress and strain, respectively. Fracture
stress–strain decreased depending on the ratio of saponification.
In terms of elastic modulus, the figures declined except for PVA9
and PVA10. (b) As in the compression graph, the portion where the
force rapidly changed was 1.37 N. (c) Optical microscopy images showed
the bend of the MN after the compression test.
Graph
of the physical properties of the MN patch and images. (a)
This graph presents the tensile strength, indicating the x-axis PVA0, PVA1, PVA3, PVA5, PVA7, PVA9, and PVA10, and the y-axis fracture stress and strain, respectively. Fracture
stress–strain decreased depending on the ratio of saponification.
In terms of elastic modulus, the figures declined except for PVA9
and PVA10. (b) As in the compression graph, the portion where the
force rapidly changed was 1.37 N. (c) Optical microscopy images showed
the bend of the MN after the compression test.
Degradability Measurement of MN
Experiments
were conducted with PVA6, PVA7, PVA8, PVA9, and PVA10 to clarify the
ratio of saponification because degradation occurred after PVA7 in
the previous research. All of the samples are the results of the initial
hydration process. In the case of PVA8, PVA9, and PVA10 films, as
shown in Figure ,
complete degradation was confirmed to have occurred with the degradability
reaching 100%. However, in the case of PVA6 and PVA7, degradation
was not found. In addition, the shape of the microneedle after immersion
in PBS has proper degradation (Figure S7). To confirm the detailed degradation ratio, degradability experiments
were conducted with PVA8, PVA7.75, PVA7.5, and PVA7.25. In the case
of PVA8, complete degradation occurred after 28 min, but that of the
remaining PVA7.75, PVA7.5, and PVA7.25 were confirmed to be partially
degraded (Figure S8). However, for PVA7.25,
degradation was not observed overall, and the characteristic swelling
behavior of general hydrogels was observed.
Figure 5
Graph of the degradability
behavior depending on the PVA ratio.
PVA8, PVA9, and PVA10 were completely degraded, reaching a weight
loss of 100%, but PVA6 and PVA7 were not degraded that present minus
weight loss, swelling in PBS.
Graph of the degradability
behavior depending on the PVA ratio.
PVA8, PVA9, and PVA10 were completely degraded, reaching a weight
loss of 100%, but PVA6 and PVA7 were not degraded that present minus
weight loss, swelling in PBS.
Measurement of the Permeability of the MN
Needles with the appropriate physical properties were subjected
to permeability experiments to see if they could penetrate the stratum
corneum of the actual skin. The elastic modulus of human skin is about
0.013 MPa,[13] and the elastic modulus of
the gelatin sheet produced at 7 wt % was confirmed to be 0.013 MPa
(Figure S3). The penetration experiment
on the 7 wt % gelatin sheets confirmed via microscopic observation
the presence of 120 blue dots normally stained on the gelatin sheet
out of a total of 120 needles. This confirmed that the microneedle
had a high permeability of 100% (Figure S4).In addition, the penetration experiment with porcine skin
showed a higher permeability of 100% (Figure S5). Moreover, the subcutaneous tissue permeation experiment of leporine
confirmed that the needle did not bend and was dissolved after permeation
during microscopic observation. Therefore, it was also confirmed to
have permeated the subcutaneous tissue (Figure S6).
TGA Measurement of PVA-Based MN Patches
TGA experiments were performed to analyze the composition of the
MN patches prepared by varying the ratio of the low degree of saponification
and the high degree of saponification in the PVA. From Figure , an increase in temperature
to 100 °C reveals the weight loss due to water evaporation. The
sudden loss of the initial weight was likely to be caused by further
thermal decomposition of large polymer chains after thermal decomposition
into smaller pieces. Due to the difference in the ratio, a slight
difference was confirmed in the first major pyrolysis. The major pyrolysis
of PVA10 and PVA9 occurred at higher temperatures. The weight loss
at up to 350 °C was about 80%, and the samples show pyrolysis
with a slow weight reduction of about 15% at 350–500 °C.
After that, a constant weight of 5% was maintained at temperatures
over 500 °C. Through this, the difference between the thermal
decomposition temperature and time is shown by the ratio of the prepared
MN patch. The high-saponification component was confirmed to have
decomposed first.
Figure 6
TGA curve of a PVA-based MN patch. At 100 °C, this
indicates
a weight loss due to water evaporation. Major pyrolysis occurred for
PVA10 and PVA9 at higher temperatures. A weight loss of up to 350
°C represents about 80% and the samples show pyrolysis with a
slow weight reduction of about 15% at 350–500 °C. After
that, a constant weight of about 5% was maintained at over 500 °C.
TGA curve of a PVA-based MN patch. At 100 °C, this
indicates
a weight loss due to water evaporation. Major pyrolysis occurred for
PVA10 and PVA9 at higher temperatures. A weight loss of up to 350
°C represents about 80% and the samples show pyrolysis with a
slow weight reduction of about 15% at 350–500 °C. After
that, a constant weight of about 5% was maintained at over 500 °C.
DSC Measurement of PVA-Based MN Patch
The results of the degradability experiment predicted that the difference
between the exploded views of PVA8 and PVA7 was due to structural
changes. The reason why there is a change in structure is that PVA
has a saponification process that switches from poly(vinyl acetate)
to poly(vinyl alcohol), which is affected by degradation because of
the transition in the structure. Therefore, the difference in the
melting points (Tm) of the PVA polymer
blend films was confirmed via DSC measurements. In the DSC curve,
the melting temperature (Tm) was 166.48
°C for PVA10, 167.10 °C for PVA9, 168.61 °C for PVA8,
180.15 °C for PVA7, and 182.64 °C for PVA6, as shown in Figure . The Tm was confirmed to be higher when the film had not degraded
than when the film had degraded. This means that more crystals are
formed in the molecular structure. Therefore, the crystal structure
was increased by increasing the ratio of the PVA with a high degree
of saponification, and this change in the crystal structure affected
the degradation degree of the PVA film.
Figure 7
DSC curve of the PVA-based
MN patch. The melting temperature (Tm)
was 166.48 °C for PVA10, 167.10 °C
for PVA9, 168.61 °C for PVA8, 180.15 °C for PVA7, and 182.64
°C for PVA6. The Tm was confirmed
to be higher when the film had not degraded than when the film had
degraded.
DSC curve of the PVA-based
MN patch. The melting temperature (Tm)
was 166.48 °C for PVA10, 167.10 °C
for PVA9, 168.61 °C for PVA8, 180.15 °C for PVA7, and 182.64
°C for PVA6. The Tm was confirmed
to be higher when the film had not degraded than when the film had
degraded.
Measurement of the Cytotoxicity of MN
Cytotoxicity experiments were conducted to find out whether it is
suitable for the human body, since it is to be used for human skin.
The experiment was conducted with a company’s product, a basic
PVA patch and a PVA patch with Niacinamide added. The cell viability
of both of the prepared patches (Figure ) was confirmed to be 80% or more, and they
were not toxic. In addition, it showed appropriate cell viability
even when compared with commercially available products. As a result
of this, the cell viability of the PVA hydrogel and the Niacinamide
hydrogel in PVA-based hydrogel is applicable to humans, observing
that cell morphology was well formed in 80–100%.[19]
Figure 8
Cytotoxicity results for the PVA films. All of the prepared
patches
were confirmed to have no toxicity with cell viability of 80% or more.
In addition, it showed suitable cell viability compared to the commercially
available products.
Cytotoxicity results for the PVA films. All of the prepared
patches
were confirmed to have no toxicity with cell viability of 80% or more.
In addition, it showed suitable cell viability compared to the commercially
available products.
Conclusions
The saponification degree
is one of the dissolution characteristics
of PVA, and it can be used to create an MN patch with controllable
degradation time by blending low-saponification PVA with high-saponification
PVA. The overall morphological stability was confirmed to be excellent
when fabricated using a mixture of molding process PVA. In addition,
the needle formation was confirmed via an optical microscope and SEM
to have formed well. The MN patch formation according to the ratio
was confirmed to be the best with a low degree of saponification and
a high degree of saponification of a 9:1 ratio (PVA9), and experiments
were conducted based on this ratio. Even when the active ingredient
was loaded into the PVA9 patch, the shape stability was maintained,
and the needle formation was well formed.The measurements of
the tensile and compression mechanical properties
confirmed that fracture stress and strain decrease depending on the
degree of saponification because of the structure through the hydrolysis
process. Also, in the elastic modulus, showed a decreasing figure,
however PVA9, 10 rose the figure. According to these results, PVA9
is the ideal sample, considering the fracture stress and strain and
the elastic modulus. The results of measuring the strength of the
needle showed that the force rapidly decreased at the portion where
the needle was bent, with the value of 1.37 N, showing sufficient
physical properties to penetrate the skin.The degradability
experiment was performed with PVA6, PVA7, PVA8,
PVA9, and PVA10, but PVA6 and PVA7 did not degrade and swell. Degradation
occurred for PVA8, PVA9, and PVA10, and the initial degradation was
fastest at PVA10, consisting of low-saponification substances, followed
by PVA9 and PVA8. Accordingly, the degradation time could be seen
to have adjusted according to the saponification ratio. In the degradability
experiment, PVA7.25, PVA7.5, PVA7.75, and PVA8 ratios were further
performed. Complete degradation occurred in PVA8, but partial degradation
occurred in PVA7.25, PVA7.5, and PVA7.75. Degradation was considered
not to occur in areas where high-saponification materials are concentrated
due to structural crystal changes according to the polymer blend and
that degradation occurred only in areas where a low degree of saponification
was concentrated.A permeability experiment was conducted to
confirm the degree of
permeation of a needle having suitable physical properties in the
gelatin sheet with the same elastic modulus as that of the actual
human skin. For convenience to observe the permeation of the needle
in the gelatin sheet, the sample was prepared by mixing methylene
blue solution to conduct the experiment. The microneedle has high
permeability of 100%. The blue dot was observed with a microscope
to confirm that the needle penetrated and dissolved. As a result of
this, it could be seen that blue dots were completely dyed on the
gelatin sheet.The DSC measurement was performed to determine
the change in the
molecular structure that is expected to affect the degree of degradability
from saponification. As a result, the change in the melting point
between PVA8, PVA9, and PVA10 that degrade and PVA7 and PVA6 that
do not degrade was confirmed. A higher melting point was confirmed
when it was not degraded. Through this, the molecular structure, that
is, the crystal structure, was found to have been formed with a higher
ratio of high-saponification PVA, indicating a higher melting point.Cytotoxicity tests were conducted to determine whether it is suitable
for use in humans. The results confirmed that the cell viability was
80% or more, which is nontoxic. In addition, sufficient cell viability
was confirmed even compared to the existing products.